Updates are available Correction dated 2020-09-09
Click to view Correction: https://doi.org/10.1186/s13018-020-01945-7
-
Authors
Keppler, Alexander M.
Saller, Maximilian M.
Alberton, Paolo
Westphal, Ines
Heidenau, Frank
Schönitzer, Veronika
Böcker, Wolfgang
Kammerlander, Christian
Schieker, Matthias
Aszodi, Attila
Neuerburg, Carl http://orcid.org/0000-0002-1373-093X
-
Funding
Funding for this research was provided by:
Friedrich-Baur-Stiftung
- License Information
-
More Information
Article History
Received: 3 October 2019
Accepted: 14 July 2020
First Online: 29 July 2020
Change Date: 9 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: All experiments received approval from the local authorities (Regierung Oberbayern; reference number 55.2-1-54-2531-112-10) and were performed in accordance with the accepted principles of the welfare of animals used in science. Consent to participate is not applicable.
: Not applicable
: MS is currently employed at Novartis Institutes for Biomedical Research (NIBR), Basel, and is a shareholder/owner of Novartis AG and LivImplant GmbH.IW was an employee at LivImplant GmbH. FH is the CEO of BioCert GmbH, Bayreuth.The other authors (AMK, CK, MMS, VS, PA, WB, AA, CN) declare that they have no competing interests.
